Adherence
Supervised moderate-to-high intensity aerobic training (60-100% VO2peak) performed three times weekly during neoadjuvant chemotherapy for breast cancer is safe and significantly improves cardiopulmonary function (VO2peak) compared to chemotherapy alone.
If you are undergoing breast cancer chemotherapy, supervised aerobic exercise (cycling) 3 times a week at moderate-to-high intensity is safe and can significantly improve your heart and lung capacity, which typically declines during treatment. Start with supervision to ensure safety and proper intensity progression.
Moderate-to-high intensity aerobic training when conducted with one-on-one supervision is a safe adjunct therapy associated with improvements in cardiopulmonary function and select PROs during neoadjuvant chemotherapy.
Why this rating
Phase II randomized trial with small sample size (n=20) and short duration (12 weeks).
Source
Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: A phase II randomized trial
Whitney Hornsby et al. · Acta Oncologica · 2013
DOI 10.3109/0284186x.2013.781673
Related findings · Adherence
- Regular physical activity (at least 150 minutes/week of moderate-intensity) reduces all-cause and cardiovascular mortality by 20-30% and lowers the risk of type 2 diabetes by 25-35%.Strong
- Increasing physical activity from a sedentary lifestyle to an active one in middle adulthood significantly reduces the risk of coronary events compared to remaining sedentary.Strong
- Resistance exercise is the only intervention capable of consistently restoring muscle function and strength in sarcopenia, partially overcoming age-related anabolic resistance.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →